ALK status in a series of non-small cell lung cancer (NSCLC) using fluorescence in situ hybridization (FISH)

被引:0
|
作者
Salido, Marta [1 ]
Galvan, Ana B. [1 ]
Gimeno, Javier [2 ]
-Rivera, Maria Rodriguez [1 ]
Pijuan, Lara [2 ]
Espinet, Blanca [1 ]
Albanell, Joan [3 ]
Arriola, Edurne [3 ]
Serrano, Sergi [2 ]
Sole, Francesc [1 ]
机构
[1] Hosp del Mar, PSM, IMIM Mol Cytogenet Lab, Dept Pathol, Barcelona, Spain
[2] Hosp del Mar, PSM, IMIM Pathol Dept, Barcelona, Spain
[3] Hosp del Mar, PSM, IMIM Oncol Dept, Barcelona, Spain
关键词
NSCLC; ALK; EML4; FISH;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
6.P55
引用
收藏
页码:S162 / S163
页数:2
相关论文
共 50 条
  • [21] STATUS OF IMMUNE THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Parums, D. V.
    DRUGS OF THE FUTURE, 2014, 39 (07) : 469 - 477
  • [22] ALK immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients
    Metro, G.
    Chiari, R.
    Giannarelli, D.
    Sidoni, A.
    Bellezza, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S14 - S15
  • [23] Evaluation of Toxicity Profile of ALK Inhibitors in Non-Small Cell Lung Cancer (NSCLC)
    Hong, S.
    Zhang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2392 - S2392
  • [24] Novel ALK specific mRNA in situ hybridization assay for non-small cell lung carcinoma
    Hirai, Noriko
    Sasaki, Takaaki
    Ohsaki, Yoshinobu
    CANCER RESEARCH, 2017, 77
  • [25] ALK gene rearrangement in Non-small Cell Lung Cancer (NSCLC) with squamous differentiation
    Cain, O.
    Mullis, T.
    Gregory, J.
    Hughes, F.
    Swift, C.
    Smith, M.
    O'Sullivan, B.
    Taniere, P.
    VIRCHOWS ARCHIV, 2015, 467 : S46 - S46
  • [26] Concordance of MET Amplification between Fluorescence In Situ Hybridization (FISH) and Next-Generation Sequencing (NGS) in Non-Small Cell Lung Carcinoma (NSCLC)
    Ren, Rongqin
    Shiller, Michelle
    Chandra, Pranil
    Crawford, Eric
    Coldren, Christopher
    Yin, Lihui
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1654 - S1654
  • [27] Feasibility of obtaining tissue for fluorescence in situ hybridization (FISH) analysis of Her1 or Her2 in advanced non-small cell lung cancer (NSCLC) patients
    Wang, L
    Polowy, CR
    Coon, J
    Leslie, W
    Stewart, I
    Bonomi, P
    LUNG CANCER, 2004, 46 : S64 - S64
  • [28] Pitfalls of RET Translocation Analysis In Non-Small Cell Lung Cancer Using In Situ Hybridization
    Geurts-Giele, W.
    Sleddens, H. F.
    Meijssen, I. C.
    Radonic, T.
    Dubbink, H. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1192 - 1192
  • [29] ALK and ROS1 Rearrangements Tested by Fluorescence In Situ Hybridization in Cytological Smears From Advanced Non-Small Cell Lung Cancer Patients
    Bozzetti, Cecilia
    Nizzoli, Rita
    Tiseo, Marcello
    Squadrilli, Anna
    Lagrasta, Costanza
    Buti, Sebastiano
    Gasparro, Donatello
    Zanoni, Daniele
    Majori, Maria
    De Filippo, Massimo
    Mazzoni, Francesca
    Maddau, Cristina
    Naldi, Nadia
    Sammarelli, Gabriella
    Frati, Caterina
    Pinto, Carmine
    Ardizzoni, Andrea
    DIAGNOSTIC CYTOPATHOLOGY, 2015, 43 (11) : 941 - 946
  • [30] Monitoring of ALK Fusions and Mutations in Advanced ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
    Mezquita, L.
    Remon, J.
    Nicotra, C.
    Noerholm, M.
    Brinkmann, K.
    Planchard, D.
    Jovelet, C.
    Auclin, E.
    Flinspach, C.
    Hurley, J.
    Skog, J.
    Gazzah, A.
    Caramella, C.
    Adam, J.
    Lacroix, L.
    Auger, N.
    Friboulet, L.
    Soria, J.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1954 - S1955